Skip to main content
SpringerLink
Log in

Synthetic Polymeric Inducers of Interferon

  • Chapter
Polymeric Materials in Medication

Part of the book series: Polymer Science and Technology ((POLS,volume 32))

Abstract

Interferon, one of the major defenses against viral infections, is produced by the body in small amounts on demand. However, its production can be stimulated by many different substances, both natural and synthetic, both small and large in molecular weight. This induction of interferon offers an alternative to the use in therapy of interferon that has been prepared by recombinant DNA technology. The purpose of this review is to describe briefly the structures of some known inducers of interferon, particularly the synthetic polymeric ones. Although the synthetic polynucleotides have shown the greatest promise in this regard, the possibilities for those inducers prepared from simpler monomer systems will be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. Isaacs and J. Lindeman, Proc. Roy. Soc. B, 147, 258 (1957).

    Article  ADS  Google Scholar 

  2. S. Pestka and S. Baron, Methods Enzymol., 78 (Interferons, Part A), 3 (1981).

    Article  Google Scholar 

  3. 3 D. A. J. Tyrrell, Nature, 184, 452 (1959).

    Article  ADS  Google Scholar 

  4. S. Baron, F. Dianzani, and G. J. Stanton, Tex. Rep. Biol. Med., 41, 1 (1982).

    Google Scholar 

  5. G. J. Galasso and J. K. Dunnick, Tex Rep. Biol. Med., 35, 479 (1977).

    Google Scholar 

  6. T. C. Merigan, Tex. Rep. Biol. Med., 35, 541 (1977).

    Google Scholar 

  7. K. Cantell, S. Hirvonen, H. Kauppinen, and G. Myllyla, Methods Enzymol., 78 (Interferon, Pt. A), 29 (1981).

    Article  Google Scholar 

  8. E. De Clercq, Methods Enzymol., 78 (Interferons, Pt. A), 227 (1981).

    Article  Google Scholar 

  9. D. A. Stringfellow, “Interferons and Interferon Inducers”, Marcel Dekker, New York (1980).

    Google Scholar 

  10. A. Khan, N. O. Hill, and G. L. Dorn, “Inteferons: Properties and Clinical Uses”, LeLand Fikes, Dallas, TX (1980).

    Google Scholar 

  11. D. A. Stringfellow, Comprehensive Therapy, 3, 25 (1977).

    Google Scholar 

  12. S. Baron, P. A. Brunnell, and S. E. Grossberg in: “Antiviral Agents and Viral Diseases of Man”, G. J. Galasso, editor, Raven Press, New York, 1979, chapter 4.

    Google Scholar 

  13. E. R. Kern, and L. A. Glascow, Pharmac. Ther., 13, 1 (1981).

    Article  Google Scholar 

  14. G. J. Minks, Microbiol. Rev., 45, 244 (1981).

    Google Scholar 

  15. Y. Inaki and K. Takemoto, Kagaku (Kyoto), 31, 908 (1976).

    Google Scholar 

  16. H. B. Levy in: “Polymeric Drugs [Proc. Int. Symp.]”, L. G. Donaruma and O. Vogl, eds., Academic Press, New York, 1978, p. 305.

    Google Scholar 

  17. M. C. Breinig and P. S. Morahan, Mod. Pharmacol.-Toxicol., 17 (Interferon Interferon Inducers: Clin. Appl.), 239 (1980).

    Google Scholar 

  18. P. B. Sehgal, L. M. Pfeiffer, and I. Tamm, Handb. Exp. Pharmacol., 61 (Chemother. Viral Infect.), 205 (1982).

    Article  Google Scholar 

  19. S. Hoffman, Z. Chem., 22, 357 (1982).

    Article  Google Scholar 

  20. P. F. Torrence and E. DeClercq, Handb. Exp. Pharmacol., 71 (Interferons: Their Appl.), 233 (1984).

    Article  Google Scholar 

  21. S. E. Grossberg, Tex. Rep. Biol. Med., 35 (Interferon Syst.), 111 (1977).

    Google Scholar 

  22. W. E. Stewart II, Tex. Rep. Biol. Med., 41, 271 (1982).

    Google Scholar 

  23. P. F. Torrence and E. De Clercq, Methods Enzymol., 78, 271 (1982).

    Google Scholar 

  24. J. Pitha and P. M. Pitha, Science, 172, 1146 (1971).

    Article  ADS  Google Scholar 

  25. J. Pitha and J. W. Kusiak in: “Anticancer and Interferon Agents”, Marcel Dekker, New York, 1984.

    Google Scholar 

  26. P. De Somer, E. De Clercq, A. Billiau, E. Schonne, and M. Claesen, J. Virol., 2, 886 (1968).

    Google Scholar 

  27. T. C. Merigan and M. S. Finkelstein, Virology, 35, 363 (1968).

    Article  Google Scholar 

  28. T. C. Merigan and W. Regelson, N. Eng. J. Med., 277, 1283 (1967).

    Article  Google Scholar 

  29. E. De Clercq and M. Luczak, Arch. Virol., 52, 151 (1976).

    Article  Google Scholar 

  30. P. Claes, A. Billiau, E. De Clercq, J. Desmyter, E. Schonne, H. Vanderhaehge, and P. De Somer, J. Virol., 5, 313 (1970).

    Google Scholar 

  31. F. I. Ershov, K. V. Moschik, A. M. Poverennyi, V. K. Podgorod-nichenko, and G. A. Popov, Byull. Eksp. Biol. Med., 94, 76 (1982).

    Article  Google Scholar 

  32. S. Suzuki, Japan Kokai 76 41, 083 06 Apr. 1976.

    Google Scholar 

  33. O. G. Andzhaparidge, T. A. Bektemirov, M. P. Burgasova, and K. Y. Oglezner, Vopr. Virusol., 4, 407 (1981).

    Google Scholar 

  34. E. De Clercq, Tex. Rep. Biol. Med., 35, 29 (1977).

    Google Scholar 

  35. V. D. Kol’tsor, L. V. Krasnova, I. G. Balandin, and E. N. Meshkova, Byull. Eksp. Biol. Med., 95, 74 (1983).

    Google Scholar 

  36. H. B. Levy, F. L. Riley, E. Lvovsky, and E. E. Stephen, Infect. Immun., 34, 416 (1981).

    Google Scholar 

  37. E. De Clercq, B. D. Stollar, and M. N. Thang, J. Gen. Virol., 40, 203 (1978).

    Article  Google Scholar 

  38. E. De Clercq, P. E. Torrence, B. D. Stollar, J. Hobbs, T. Fukai, N. Kakiuchi, and M. Ikehara, Eur. J. Biochem., 88, 341 (1978).

    Article  Google Scholar 

  39. Tokuyama Soda Co., Ltd., Jpn. Kokai Tokyo Koho JP 59 70, 618 [84 70, 618] 21 Apr. 1984.

    Google Scholar 

  40. F. I. Ershov, A. N. Fomina, V. F. Krylov, N. P. Obrosova-Serova, S. S. Grigoryan A. N. Slepushkin, K. V. Moshchik, V. I. Balashov, I. A. Grusinskaya, and N. A. Smagulova, Vopr. Virusol., 4, 418, 423 (1981).

    Google Scholar 

  41. H. B. Methods. Enzymol., 78 (Interferons, Part A), 242 (1981).

    Google Scholar 

  42. K. Reuss, K. H. Scheit and O. Saiko, Nucleic Acids Res., 3, 2861 (1976).

    Article  Google Scholar 

  43. P. F. Torrence, E. De Clercq, J. A. Walters, and B. Witkop, Biochemistry, 13, 4400 (1974).

    Article  Google Scholar 

  44. E. De Clercq, B. D. Stoller, J. Hobbs, T. Fukui, N. Kakiuchi, and M. I. Kehara, Eur. J. Biochem., 107, 279 (1980).

    Article  Google Scholar 

  45. A. S. Levine, M. Sivulich, P. H. Wiernik, and H. B. Levy, Cancer Res., 39, 1645 (1979).

    Google Scholar 

  46. H. B. Levy, and F. L. Riley, U. S. Patent Appl. US 292, 583, 18 June 1982.

    Google Scholar 

  47. K. Wasche, S. R. Wasche, S. Hoffman, and W. Witkowski, Acta Biol. Med. Ger., 38, 739 (1979).

    Google Scholar 

  48. P. M. Pitha, Tex. Rep. Biol. Med., 35 (Interferon Syst.), 39 (1977).

    Google Scholar 

  49. P. M. Pitha, Methods Enzymol., 78 (Interferons, Part A), 236 (1981).

    Article  Google Scholar 

  50. D. F. Bradley, J. Macromol. Sci.-Chem., A4, 741 (1970).

    Google Scholar 

  51. A. E. Munson, K. L. White, and P. C. Klykken in: “Augmenting Agents in Cancer Therapy”, E. M. Hersh, ed., Raven Press, New York, 1981, p. 329.

    Google Scholar 

  52. R. S. McCord, M. K. Breinig, and P. S. Morahan, Antimicrobial Agents and Chemotherapy, 10, 28, (1976).

    Article  Google Scholar 

  53. D. S. Breslow, Pure and Appl. Chem., 46, 103 (1976).

    Article  Google Scholar 

  54. R. A. Carrano, F. K. Kinoshita, A. R. Imondi, and J. D. Iuliucci in “Augmenting Agents in Cancer Therapy”, Progress in Cancer Research, Vol. 16, E. M. Hersh, ed., Raven Press, New York, 1981, p. 345.

    Google Scholar 

  55. E. M. Hodnett, Polymer News, 8, 162 (1982).

    Google Scholar 

  56. S. Hoffman, W. Witkowsky, K. Wasche, and S. R. Wasche, Z. Chem., 17, 61 (1977).

    Article  Google Scholar 

  57. S. Hoffman, W. Witkowsky, and K, Wasche, Z. Chem., 16, 484 (1976).

    Google Scholar 

  58. P. J. Grob, H. I. Joller-Jemelka, U. Binswanger, K. Zarba, C. Descoeudres, and M. Fernex, Eur. J. Clin. Microbiol., 3, 195 (1984).

    Article  Google Scholar 

  59. L. Gros, H. Ringsdorf, and H. Schupp, Angew. Chem. Int. Ed. Engl., 20, 305 (1981).

    Article  Google Scholar 

  60. P. S. Morahan in: “Augmenting Agents in Cancer Therapy”, Progress in Cancer Research, Vol. 16, E. M. Hersh, ed., Raven Press, New York, 1981, p. 185.

    Google Scholar 

  61. E. M. Hodnett, Polymer News, 8, 323 (1983).

    Google Scholar 

  62. L. G. Donaruma, Progress Polymer Sci., 4, 1 (1974).

    Article  Google Scholar 

  63. “Polymers in Biology and Medicine, Vol. I, Anionic Polymeric Drugs”, L. G. Donaruma, R. M. Ottenbrite, and O. Vogl, eds., John Wiley, New York, 1980.

    Google Scholar 

  64. W. Regelson, Adv. Chemother., 3, 303 (1968).

    Google Scholar 

  65. W. Regelson in: “Water-Soluble Polymers”, N. M. Bikales, editor, Plenum Press, 1973, p. 161.

    Google Scholar 

  66. W. Regelson, J. Polymer Science, Polymer Symposium, 66, 483 (1979).

    Article  Google Scholar 

  67. “Biological Activities of Polymers”, C. E. Carraher, Jr. and C. G. Gebelein, editors, ACS Series 186, American Chemical Society, Washington, DC, 1982.

    Google Scholar 

  68. R. M. Ottenbrite, and G. G. Butler in: “Anticancer and Interferon Agents”, Marcel Dekker, New York, 1984.

    Google Scholar 

  69. P. O. P. Ts’o, P. S. Miller, and J. J. Greene, Prog. Cancer Res. Ther., 28 (Dev. Target-Oriented Anticancer Drugs), 189 (1983).

    Google Scholar 

  70. W. Regelson, S. Kuhar, M. Tunis, J. Fields, J. Johnson, and E. Glusenkamp, Nature, 186, 778 (1960).

    Article  ADS  Google Scholar 

  71. E. M. Hodnett and J. Tien Hai Tai, J. Med. Chem., 17, 1335 (1974).

    Article  Google Scholar 

  72. E. M. Hodnett, J. Amirmoazzami, and J. Tien Hai Tai, J. Med. Chem., 21, 652 (1978).

    Article  Google Scholar 

  73. E. M. Hodnett, A. Wai Woo, and F. A. French, Eur. J. Med. Chem., 13, 652 (1978).

    Google Scholar 

  74. J. H. Dean, M. L. Padarathsingh, and L. Kays, Cancer Treatment Reports, 62, 1807 (1978).

    Google Scholar 

  75. P. S. Morahan, D. W. Barnes, and A. E. Munson, Cancer Treatment Reports, 62, 1797 (1978).

    Google Scholar 

  76. N. A. Pavlidis, R. M. Schaltz, M. A. Chirigos, and J. Luetzeler, Cancer Treatment Reports, 62, 1817 (1978).

    Google Scholar 

  77. M. A. Chirigos and W. A. Stylos, Cancer Res., 40, 1967 (1980).

    Google Scholar 

  78. R. Ottenbrite, E. Goodell, and A. Munson, Polymer, 18, 461 (1977).

    Article  Google Scholar 

  79. R. L. Stofi and D. S. Martin, Cancer Treatment Reports, 62, 1791 (1978).

    Google Scholar 

  80. S. J. Mohr, M. A. Chirigos, F. S. Fuhrman, and J. W. Pryor, Cancer Res., 35, 3750 (1978).

    Google Scholar 

  81. W. Wierenga, Ann. Rep. Med. Chem., 17, 151 (1982).

    Article  Google Scholar 

  82. E. De Clercq and P.F. Torrence, Tex. Rep. Biol. Med., 41, 76 (1982).

    Google Scholar 

  83. D. R. Stryer, W. A. Carter, D. H. Gillespie, I. Brodsky, C. Baglioni, J. M. Zarling, J. J. Greene, and P. O.P. Ts’o, Proc. Am. Assn. Cancer Res., 22, 160 (1981).

    Google Scholar 

  84. E. De Clercq, Antibiotics Chemother., 27, 251 (1980).

    Google Scholar 

  85. H. B. Levy, E. Lvovsky, F. Riley, D. Harrington, A. Anderson, J. Moe, J. Hilfenhaus, and E. Stephen, Ann. N. Y. Acad. Sci., 350, 33 (1980).

    Article  ADS  Google Scholar 

  86. R. F. Oldham, Cancer Treat. Rep., 68, 221 (1984).

    Google Scholar 

  87. P. S. Sunkara, N. J. Prakash, A. L. Rosenberger, A. C. Hagan, P. J. Lachmann, and G. D. Mayer, Cancer Res., 44, 2799 (1984).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Oklahoma State University, Stillwater, OK, 74078, USA

    Ernest M. Hodnett

Authors
  1. Ernest M. Hodnett
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Youngstown State University, Youngstown, Ohio, USA

    Charles G. Gebelein

  2. Florida Atlantic University, Boca Raton, Florida, USA

    Charles E. Carraher Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hodnett, E.M. (1985). Synthetic Polymeric Inducers of Interferon. In: Gebelein, C.G., Carraher, C.E. (eds) Polymeric Materials in Medication. Polymer Science and Technology, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2245-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2245-8_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2247-2

  • Online ISBN: 978-1-4899-2245-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation